Bacteria in head and neck tumor stimulate immunotherapy resistance by attracting immune cells and creating a shield.

Studies published in Nature Cancer reveal how bacterial presence in head and neck cancers affects treatment response, ...

A novel tumor suppressor, BATF2, can be silenced by factors in the tumor microenvironment, leading to a reduced immune ...

MSK radiation oncologist Dr. Nadeem Riaz and colleagues discovered that bacteria inside tumors can undermine the effects of immunotherapy. In cancer research, failure can lead to an important ...

Head and neck cancer is a broad term for several types of cancers that include the mouth (oral cavity), throat (pharynx), voice box (larynx), sinuses and nose cavity, and salivary glands. Head and ...

Tel Aviv University (TAU) researchers say they have successfully eliminated 50 percent of head and neck tumors in mouse models using CRISPR gene editing technology. The breakthrough study, led by Dr.

BATF2 is a new type of tumor suppressor that can be epigenetically silenced by high levels of glutamine in the tumor microenvironment Glutamine silences BATF2 and leads to a weakened immune response ...

GT Biopharma, Inc. (the "Company") (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company's proprietary TriKE(R) natural killer (NK ...

Head and neck cancers affect the tissues of the mouth, throat, sinuses, and surrounding areas. They can impact crucial functions like breathing, swallowing, and talking. There are several types of ...

A new blood test can identify cancers of the head and neck caused by the human papillomavirus (HPV) up to 10 years before symptoms appear. This is the discovery of Mass General Brigham researchers who ...